Sector: Pharmaceuticals & Biotechnology

Large Cap

Rubicon Research Share Price

RUBICON

₹1,766

41.30(2.39%)

24th Aug 2026 | 3:28 PM

NSE : RUBICON

Open Free Demat Account

Rubicon Research Performance

Price Movement

₹1766.00

₹1725.10

₹1780.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1766.00

₹570.75

₹1820.10

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,780.00

Low₹1,725.10

Open at₹1,744.80

Prev Close₹1,724.70

Volumes3.34 L

Avg Price₹1,756.34

Lower Circuit₹1,379.80

Upper Circuit₹2,069.60

Historical Performance

3M High₹1,820.10

3M Low₹940.15

1 Yr High₹1,820.10

1 Yr Low₹570.75

3 Yr High₹1,820.10

3 Yr Low₹570.75

5 Yr High₹1,820.10

5 Yr Low₹570.75

Summary

As of 24-08-2026 23:59, Rubicon Research Ltd. share price today is ₹0, with a change of ₹-1724.70 (-100.00%) from the previous close of ₹1724.7. The stock opened at ₹1744.8 and traded between ₹1725.1 and ₹1780, with a total traded volume of 333984 shares. The company has a market capitalization of ₹28549.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1820.1 and ₹570.75, respectively.

Rubicon Research Ltd. valuation metrics include a P/E ratio of 99.1, EPS of ₹15.52, and book value of ₹20.80. Profitability indicators show ROE of 19.14% along with a dividend yield of 0.1%. Rubicon Research Ltd. has reported revenue of ₹1935.8 Cr and net profit of ₹288.22 Cr.

Rubicon Research Ltd. technical indicators include Day RSI at 64.22, Day MFI at 75.3, Day ADX at 32.68. Additional indicators include Commodity Channel Index (CCI) at 93.2 and Williams %R at -26.61. Momentum indicators show Day MACD at 85.72, Day MACD Signal Line at 75.36, DayATR at 73.43. Rate of Change indicators for Rubicon Research Ltd. include ROC125 at 118.73 and ROC21 at 13.07.

Exponential moving averages include EMA5 at ₹1742.1, EMA10 at ₹1704, EMA12 at ₹1688.8, EMA20 at ₹1636.7, EMA26 at ₹1603.1, EMA50 at ₹1484.8, EMA100 at ₹1293.6, EMA200 at ₹987. Simple moving averages include SMA5 at ₹1777.4, SMA10 at ₹1703.2, SMA20 at ₹1616, SMA30 at ₹1570, SMA50 at ₹1490.8, SMA100 at ₹1230.5, SMA150 at ₹1069.3, SMA200 at ₹966.4.

Support levels for Rubicon Research are placed at First Support ₹1691.80, Second Support ₹1658.90, Third Support ₹1616.80. Resistance levels are seen at First Resistance ₹1766.80, Second Resistance ₹1808.90, Third Resistance ₹1841.80. Rubicon Research Ltd. shareholding pattern shows promoter holding at 59.76%, FII holding at 7.52%, DII holding at 0%, public holding at 23.29%.

Rubicon Research Fundamentals

Market Cap

High in industry

28,549.30 Cr.

PE Ratio (TTM)

High in industry

99.10

Dividend Yield

Low in industry

0.10

Net Profit TTM

89.5% incr over last year

288.22

Net Profit Growth

89.5% incr over last year

288.22

PEG Ratio

Above industry Median

1.10

ROE

23% decr over last year

19.14

Operating Revenue TTM

1,935.80

Operating Revenue Growth

46.7% incr over last year

Book Value

High in industry

20.80

MFI

MFI Overbought

75.30

RSI

RSI is mid-range

64.22

EPS (TTM)

15.52

Debt to Equity

0.20

Face Value

Operating Profit Margin Qtr.

22.72

Operating Profit Qtr.

129.12

Net Profit Qtr.

84.78

Operating Revenue Qtr.

534.34

PB Ratio

20.80

Rubicon Research Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	427.73	389.88	301.71	336.47	278.03
Operating Expense	302.90	283.71	239.46	257.37	214.88
Operating Profit	124.83	106.17	62.25	79.10	63.14
Depreciation	10.57	10.17	9.51	9.78	8.30
Interest	6.01	5.40	7.51	9.21	8.85
Tax	28.21	24.16	12.35	15.82	12.28
Net Profit	82.45	70.02	37.18	45.81	35.15

Rubicon Research Technicals

Rubicon Research Ltd. EMA & SMA

₹1766.00

5.40 (0.31%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1742.1

Day EMA10 ₹1704

Day EMA12 ₹1688.8

Day EMA20 ₹1636.7

Day EMA26 ₹1603.1

Day EMA50 ₹1484.8

Day EMA100 ₹1293.6

Day EMA200 ₹987

Rubicon Research Support and Resistance

Resistance

First Resistance₹1766.80

Second Resistance₹1808.90

Third Resistance₹1841.80

Support

First Support₹1691.80

Second Support₹1658.90

Third Support₹1616.80

Technical Indicators

Day RSI64.22

Day MFI75.30

Day ADX32.68

Day Commodity Channel Index93.20

William-26.61

Day MACD85.72

Day MACD Signal Line75.36

Day ATR73.43

Day ROC125118.73

Day ROC2113.07

Rubicon Research Shareholding Pattern

Held By	Dec 2025	Mar 2026	Jun 2026
Promoter	60	59.9	59.8
FII	8	7.5	7.5
DII	9.4	10.1	9.5
Public	22.6	22.6	23.3

Rubicon Research Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.49 L	3.03 L	49.41%
Week	3.41 L	10.77 L	31.66%
1 Month	1.74 L	4.45 L	39.01%
6 Month	1.52 L	4.5 L	33.74%

Rubicon Research SWOT Analysis

Strengths34

Weakness7

Opportunity4

Threats1

Benjamin Graham Value Screen

Expensive Stars (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Stringent DVM Screener

Combined DVM and Piotroski Scores Screener (subscription)

Weekly Screener: High Momentum Score Stocks (subscription)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 4 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Highest Recovery from 52 Week Low

RSI indicating price strength

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Rubicon Research Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
07 Aug, 2026	1.5	FINAL	07 Aug, 2026	Equity Share

Rubicon Research Stock Comparison

Financials	Anthem Biosciences Ltd.	Neuland Laboratories Ltd.	Ipca Laboratories Ltd.	J B Chemicals & Pharmaceuticals Ltd.	GlaxoSmithKline Pharmaceuticals Ltd.
Price (₹)	₹883.60	₹22,901	₹1,921	₹2,506	₹2,930
% Change	1.39%	-1.72%	0.51%	0.00%	0.96%
Revenue TTM (₹ Cr)	₹2,002.34	₹2,371.81	₹10,125.58	₹4,147.79	₹3,954.94
Net Profit TTM (₹ Cr)	₹575.94	₹497.77	₹1,309.80	₹709.46	₹1,068.15
PE TTM	85.20	60.10	37.00	54.50	46.00
1 Year Return	5.9	67.78	34.74	37.82	3.69
ROCE	27.56	23.10	17.23	22.50	54.54

Similar Stocks

PFIZER

Pfizer Ltd.

₹ 4886.00

-1.85%

ABBOTINDIA

Abbott India Ltd.

₹ 26450.00

+0.84%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4886.50

-0.20%

LUPIN

Lupin Ltd.

₹ 2188.00

-0.63%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1190.00

+1.30%

CIPLA

Cipla Ltd.

₹ 1437.90

+0.40%

SAILIFE

Sai Life Science Ltd.

₹ 1436.80

-1.41%

EMCURE

Emcure Pharmaceuticals Ltd.

₹ 1862.00

-0.05%

MANKIND

Mankind Pharma Ltd.

₹ 2374.50

-0.40%

PPLPHARMA

Piramal Pharma Ltd.

₹ 212.43

-0.58%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3171.00

+0.06%

GLAND

Gland Pharma Ltd.

₹ 2811.90

-0.26%

LAURUSLABS

Laurus Labs Ltd.

₹ 1801.00

-0.06%

ALKEM

Alkem Laboratories Ltd.

₹ 5350.00

-0.93%

BIOCON

Biocon Ltd.

₹ 409.40

-1.48%

DIVISLAB

Divi's Laboratories Ltd.

₹ 8496.00

-1.17%

GRANULES

Granules India Ltd.

₹ 857.00

-0.13%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3581.00

-1.62%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1103.80

-1.45%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2390.70

+3.14%

WOCKPHARMA

Wockhardt Ltd.

₹ 1902.00

+0.83%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1608.00

-0.82%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1910.00

+0.40%

FAQ's on RUBICON

What is the current share price of Rubicon Research Ltd.?

As of 21 August 2026 at 10:01 AM, the share price for Rubicon Research Ltd. is ₹ 1766 on the NSE and ₹ 1772 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Rubicon Research Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 21 August 2026, the market cap for Rubicon Research Ltd. is approximately ₹ 28549.3 Cr.

What are the PE and PB ratios for Rubicon Research Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Rubicon Research Ltd. is 99.1, and the Price-to-Book (PB) ratio is 20.8.

What is the 52-Week High and Low for Rubicon Research Ltd.?

Over the past 52 weeks, the highest price reached by Rubicon Research Ltd. shares was ₹ 1820.1, and the lowest price was ₹ 570.75.

What is the current dividend yield for Rubicon Research Ltd.?

As of 21 August 2026, the dividend yield for Rubicon Research Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Rubicon Research Ltd.?

Significant shareholdings in Rubicon Research Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Rubicon Research Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Rubicon Research Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Rubicon Research Ltd.?

Rubicon Research Ltd. last declared a FINAL dividend of ₹ 1.5 per share for the financial period ending 2026. The record date was set as 2026-08-07, and the payment was/is scheduled around 2026-08-07. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy